These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
315 related articles for article (PubMed ID: 30136085)
1. Vitamin D and calcium kidney stones: a review and a proposal. Tavasoli S; Taheri M Int Urol Nephrol; 2019 Jan; 51(1):101-111. PubMed ID: 30136085 [TBL] [Abstract][Full Text] [Related]
2. Vitamin D and kidney stone disease. Tang J; Chonchol MB Curr Opin Nephrol Hypertens; 2013 Jul; 22(4):383-9. PubMed ID: 23739765 [TBL] [Abstract][Full Text] [Related]
3. Vitamin D status in patients with recurrent kidney stones. Pipili C; Oreopoulos DG Nephron Clin Pract; 2012; 122(3-4):134-8. PubMed ID: 23712072 [TBL] [Abstract][Full Text] [Related]
4. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group. Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F; Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027 [TBL] [Abstract][Full Text] [Related]
5. Analysis of vitamin D deficiency in calcium stone-forming patients. Girón-Prieto MS; Del Carmen Cano-García M; Arrabal-Polo MÁ; Poyatos-Andujar A; Quesada-Charneco M; de Haro-Muñoz T; Arias-Santiago S; Arrabal-Martín M Int Urol Nephrol; 2016 Aug; 48(8):1243-1246. PubMed ID: 27093967 [TBL] [Abstract][Full Text] [Related]
6. Vitamin D Repletion in Kidney Stone Formers: A Randomized Controlled Trial. Ferroni MC; Rycyna KJ; Averch TD; Semins MJ J Urol; 2017 Apr; 197(4):1079-1083. PubMed ID: 27765695 [TBL] [Abstract][Full Text] [Related]
7. The Prevalence of Vitamin D Deficiency, Its Predisposing Factors and Association with 24-hour Urine Metabolites Among Iranian Kidney Stone Formers. Tavasoli S; Taheri F; Bagheri Amiri F; Borumandnia N; Basiri A; Parvin M; Taheri M Iran J Kidney Dis; 2021 Jul; 15(4):263-269. PubMed ID: 34278997 [TBL] [Abstract][Full Text] [Related]
9. [Effect of etidronate disodium (EHDP) on calcium oxalate renal stones induced by synthetic 1 alpha(OH) vitamin D3 and ethylene glycol in rats]. Kawamura J; Nonomura M; Okada Y; Yoshida O; Takashima M; Itokawa Y Hinyokika Kiyo; 1985 May; 31(5):749-62. PubMed ID: 3931444 [TBL] [Abstract][Full Text] [Related]
10. Vitamin D deficiency is prevalent among idiopathic stone formers, but does correction pose any risk? Johri N; Jaeger P; Ferraro PM; Shavit L; Nair D; Robertson WG; Gambaro G; Unwin RJ Urolithiasis; 2017 Dec; 45(6):535-543. PubMed ID: 27981376 [TBL] [Abstract][Full Text] [Related]
11. Effect of two vitamin D repletion protocols on 24-h urine calcium in patients with recurrent calcium kidney stones and vitamin D deficiency: a randomized clinical trial. Sardari Masihi L; Borumandnia N; Taheri M; Basiri A; Imani H; Jalali S; Tavasoli S Eur J Med Res; 2023 Jul; 28(1):246. PubMed ID: 37481570 [TBL] [Abstract][Full Text] [Related]
12. Metabolic effects of cholecalciferol supplementation in patients with calcium nephrolithiasis and vitamin D deficiency. Vitale C; Marangella M; Bermond F; Fabbrini L; Tricerri A World J Urol; 2021 Feb; 39(2):597-603. PubMed ID: 32367158 [TBL] [Abstract][Full Text] [Related]
13. Nephrocalcinosis in Calcium Stone Formers Who Do Not have Systemic Disease. Bhojani N; Paonessa JE; Hameed TA; Worcester EM; Evan AP; Coe FL; Borofsky MS; Lingeman JE J Urol; 2015 Nov; 194(5):1308-12. PubMed ID: 25988516 [TBL] [Abstract][Full Text] [Related]
14. Effect of vitamin D repletion on urinary calcium excretion among kidney stone formers. Leaf DE; Korets R; Taylor EN; Tang J; Asplin JR; Goldfarb DS; Gupta M; Curhan GC Clin J Am Soc Nephrol; 2012 May; 7(5):829-34. PubMed ID: 22422535 [TBL] [Abstract][Full Text] [Related]
15. Calcium and Vitamin D Supplementation and Their Association with Kidney Stone Disease: A Narrative Review. Bargagli M; Ferraro PM; Vittori M; Lombardi G; Gambaro G; Somani B Nutrients; 2021 Dec; 13(12):. PubMed ID: 34959915 [TBL] [Abstract][Full Text] [Related]
16. Metabolic abnormalities and the medical management of calcium oxalate nephrolithiasis. Chandhoke PS Minerva Urol Nefrol; 2005 Mar; 57(1):9-16. PubMed ID: 15944517 [TBL] [Abstract][Full Text] [Related]
17. Changes in renal papillary density after hydration therapy in calcium stone formers. Ferraro PM; Vittori M; Macis G; D'Addessi A; Lombardi G; Palmisano C; Gervasoni J; Primiano A; Bassi PF; Gambaro G BMC Urol; 2018 Nov; 18(1):101. PubMed ID: 30419887 [TBL] [Abstract][Full Text] [Related]
18. Uric acid: an abettor or protector in calcium oxalate urolithiasis? Biochemical study in stone formers. Srinivasan S; Kalaiselvi P; Sakthivel R; Pragasam V; Muthu V; Varalakshmi P Clin Chim Acta; 2005 Mar; 353(1-2):45-51. PubMed ID: 15698589 [TBL] [Abstract][Full Text] [Related]
19. Kidney stone formers have more renal parenchymal crystals than non-stone formers, particularly in the papilla region. Okada A; Hamamoto S; Taguchi K; Unno R; Sugino T; Ando R; Mizuno K; Tozawa K; Kohri K; Yasui T BMC Urol; 2018 Mar; 18(1):19. PubMed ID: 29530009 [TBL] [Abstract][Full Text] [Related]
20. Three pathways for human kidney stone formation. Coe FL; Evan AP; Worcester EM; Lingeman JE Urol Res; 2010 Jun; 38(3):147-60. PubMed ID: 20411383 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]